HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice.

Abstract
Increased sarcoplasmic reticulum (SR) Ca2+ leak via the cardiac ryanodine receptor/calcium release channel (RyR2) is thought to play a role in heart failure (HF) progression. Inhibition of this leak is an emerging therapeutic strategy. To explore the role of chronic PKA phosphorylation of RyR2 in HF pathogenesis and treatment, we generated a knockin mouse with aspartic acid replacing serine 2808 (mice are referred to herein as RyR2-S2808D+/+ mice). This mutation mimics constitutive PKA hyperphosphorylation of RyR2, which causes depletion of the stabilizing subunit FKBP12.6 (also known as calstabin2), resulting in leaky RyR2. RyR2-S2808D+/+ mice developed age-dependent cardiomyopathy, elevated RyR2 oxidation and nitrosylation, reduced SR Ca2+ store content, and increased diastolic SR Ca2+ leak. After myocardial infarction, RyR2-S2808D+/+ mice exhibited increased mortality compared with WT littermates. Treatment with S107, a 1,4-benzothiazepine derivative that stabilizes RyR2-calstabin2 interactions, inhibited the RyR2-mediated diastolic SR Ca2+ leak and reduced HF progression in WT and RyR2-S2808D+/+ mice. In contrast, β-adrenergic receptor blockers improved cardiac function in WT but not in RyR2-S2808D+/+ mice.Thus, chronic PKA hyperphosphorylation of RyR2 results in a diastolic leak that causes cardiac dysfunction. Reversing PKA hyperphosphorylation of RyR2 is an important mechanism underlying the therapeutic action of β-blocker therapy in HF.
AuthorsJian Shan, Matthew J Betzenhauser, Alexander Kushnir, Steven Reiken, Albano C Meli, Anetta Wronska, Miroslav Dura, Bi-Xing Chen, Andrew R Marks
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 120 Issue 12 Pg. 4375-87 (Dec 2010) ISSN: 1558-8238 [Electronic] United States
PMID21099115 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Adrenergic beta-Antagonists
  • Ryanodine Receptor Calcium Release Channel
  • Cyclic AMP-Dependent Protein Kinases
Topics
  • Adrenergic beta-Antagonists (pharmacology)
  • Amino Acid Substitution
  • Animals
  • Calcium Signaling (drug effects)
  • Cyclic AMP-Dependent Protein Kinases (metabolism)
  • Heart Failure (drug therapy, genetics, metabolism)
  • Mice
  • Mice, Mutant Strains
  • Mice, Transgenic
  • Mutation, Missense
  • Myocardial Infarction (metabolism)
  • Myocardium (metabolism)
  • Phosphorylation
  • Ryanodine Receptor Calcium Release Channel (genetics, metabolism)
  • Sarcoplasmic Reticulum (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: